Percheron Therapeutics Ltd (ASX:PER – Get Free Report) insider Charmaine Gittleson acquired 1,666,666 shares of the business’s stock in a transaction that occurred on Tuesday, December 31st. The shares were purchased at an average cost of A$0.01 ($0.01) per share, for a total transaction of A$14,999.99 ($9,316.77).
Percheron Therapeutics Price Performance
About Percheron Therapeutics
Pernod Ricard SA produces and sells wines and spirits worldwide. It offers its products under various brands. The company was founded in 1805 and is headquartered in Paris, France.
Recommended Stories
- Five stocks we like better than Percheron Therapeutics
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Insiders Are Selling, But These 3 Stocks Are Must-Buys
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Rivian Defies Doubters: Delivery Triumph Fuels Stock Surge
- 3 Warren Buffett Stocks to Buy Now
- Hindenburg Short Report Slams Carvana Over Alleged ‘Grift’
Receive News & Ratings for Percheron Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Percheron Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
